Antiretroviral preexposure prophylaxis ( PrEP ) , using tenofovir disoproxil fumarate ( TDF ) and combination emtricitabine/tenofovir disoproxil fumarate ( FTC+TDF ) , is efficacious for prevention of human immunodeficiency virus ( HIV ) acquisition .